guide

Amidst the ongoing Q4 FY24 earnings season, Goldman Sachs analysts have conducted a thorough recalibration of their projections for the Indian pharmaceutical sector. This recalibration takes into account a wide spectrum of variables, ranging from monthly sales data to currency fluctuations. One of the key observations made by the analysts is that the sector is
0 Comments
Particle Health and Epic Systems are currently embroiled in a dispute over data-sharing practices, with Epic filing a formal complaint against Particle citing concerns about the accuracy of record retrievals. Both companies are members of the Carequality network, which facilitates the exchange of patient information on a large scale. Despite the dispute, Particle Health stated
0 Comments